Skip to content
DataLookout
Menu

NCT07730294

Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery

StatusRecruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved at least 31 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date pushed from Oct 2026 to Nov 2026
    • Primary and study completion dates: Oct 2028 to Nov 2028
    • Site details revised
  2. Notable Start date: Aug 2026 to Oct 2026
    • Eligibility criteria expanded, about 13 words
    • Primary and study completion pushed from Aug 2028 to Oct 2028
    • Secondary endpoints: details revised at 5 of 5 entries
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in post-operative pain measured by the Numeric Pain Rating Scale (NPRS)
Timeframe: Pre-op up to 8 weeks after last drug administration
Change in post-operative pain measured by monitoring of pain medication usage
Timeframe: Pre-op up to 8 weeks after last drug administration

Secondary (5)

Changes in participant reported depression as measured by the Beck Depression Inventory (BDI-II)
Changes in participant reported anxiety as measured by the Beck Anxiety Inventory (BAI)
Changes in participant reported anxiety as measured by the Generalized Anxiety Disorder-7
Changes in participant reported depression as measured by the Patient Health Questionnaire-9
Change in neural functioning measured by Electroencephalography (EEG)/Event-Related Potential (ERP)

Arms and interventions

Low Dose OxytocinExperimental

Participants in this arm will receive low dose oxytocin beginning one week prior to surgery, continues on the day of the surgery, and extends through the week following the surgery.

High Dose OxytocinExperimental

Participants in this arm will receive high dose oxytocin beginning one week prior to surgery, continues on the day of the surgery, and extends through the week following the surgery.

Saline-Mg solutionPlacebo comparator

Participants in this arm will receive placebo beginning one week prior to surgery, continues on the day of the surgery, and extends through the week following the surgery.

Drugs: Oxytocin (Low dose), Oxytocin (High dose), Placebo (saline)

Sites

1 site in 1 country

  • Yale UniversityNew Haven, Connecticut, United States